FusoLab is one of the advanced biotech R&D centers in China. Major team members who are from USA, Europe, Japan and China are expertise in molecular biology, proteomics, structural biology, pharmacy and chemistry. The team is dedicated to the discovery and development of novel drugs against serious virus infections.

Peptide group: Aiming at higher productivity with lower cost, we are using solid-phase peptide synthesis to optimize the process and upscale to industrial level.

Organic Chemistry group: A series of compounds are designed based on 3-D structure of target protein, and are synthesized. The potential compounds will be optimized from the screening information. The process of the final drug candidate will also be optimized for larger scale production.

Molecular Biology group: The reliable and efficient cell-based assay is established. The series of designed compounds are screened. The final drug candidate is selected for further preclinical evaluation.

Quality Management Dept: We are establishing the international standards for drug R&D and CMC.